Assura PLC Acquisition and Issue of Consideration Shares (6527M)
January 22 2016 - 2:00AM
UK Regulatory
TIDMAGR
RNS Number : 6527M
Assura PLC
22 January 2016
22 January 2016
Assura plc
Acquisition and Issue of Consideration Shares
Assura plc ("Assura"), the UK REIT and leading primary care
property investor and developer announces that on 21 January 2016,
it acquired Malmesbury Medical Enterprise Limited from its former
shareholders Kate Badcock, David Charles, Angela Charles, Nigel
Pickering, Janet Pickering, John Pettit, Philippa Pettit, Jaqueline
Neale, John Harrison, Pamela Harrison, Thomas Estcourt, Sonia
Munnelly & David Grogan (together, the "Sellers"). As part of
the consideration payable under the terms of the acquisition,
Assura has agreed to issue to the Sellers 876,222 ordinary shares
of 10 pence each ("Ordinary Shares"). These new shares will rank
pari passu with the existing Ordinary Shares.
Application has been made to the UK Listing Authority and to the
London Stock Exchange for the new shares to be admitted to the
Official List and to trading on the London Stock Exchange's main
market for listed securities ("Admission"). It is expected that
Admission will occur at 8.00 a.m. on 27 January 2016. Based on the
closing share price on 20 January 2016 of 52.6 pence per share, the
new shares issued are valued at GBP0.5 million.
For the purposes of the Financial Conduct Authority's Disclosure
and Transparency Rules ("DTRs"), the issued ordinary share capital
of the Company following Admission on 27 January 2016 will consist
of 1,637,706,738 Ordinary Shares. This total voting rights figure
may be used by shareholders as the denominator for the calculations
by which they will determine whether they are required to notify
their interests in, or a change to their interest in, the Company
under the DTRs.
For more information, please contact:
Assura plc Tel: 01925 420660
Orla Ball
Carolyn Jones
Finsbury Tel: 0207 251 3801
Gordon Simpson
Notes to Editors
Assura plc, a constituent of the FTSE 250, is a UK REIT and
long-term investor in and developer of primary care property. The
company, headquartered in Warrington, works with GPs, health
professionals and the NHS to create innovative property solutions
in order to facilitate delivery of high quality patient care in the
community. At 30 September 2015, Assura's property portfolio was
valued at GBP1,030 million.
Further information is available at www.assuraplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDFLFLQFFXBBE
(END) Dow Jones Newswires
January 22, 2016 02:00 ET (07:00 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2023 to Apr 2024